Myriad Genetics: Q3 Earnings Insights

Myriad Genetics: Q3 Earnings Insights

Myriad Genetics MYGN reported its Q3 earnings results on Tuesday, November 1, 2022 at 09:05 AM.

Here's what investors need to know about the announcement.


Myriad Genetics missed estimated earnings by 216.67%, reporting an EPS of $-0.19 versus an estimate of $-0.06.

Revenue was down $10.90 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 0.22% increase in the share price the next day.

Here's a look at Myriad Genetics's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 0.01 -0.07 -0.02 -0.02
EPS Actual 0.04 -0.03 -0.02 -0.02
Revenue Estimate 171.00M 156.62M 163.40M 165.04M
Revenue Actual 179.30M 164.90M 160.80M 167.30M

To track all earnings releases for Myriad Genetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings